How Is the Lung Stent Market Evolving Globally?

The Lung Stent Market is gaining momentum as healthcare providers increasingly adopt minimally invasive solutions to manage airway obstructions caused by respiratory disorders.

Globally, the market reached a value of approximately USD 157.55 million in 2025 and is projected to grow at a CAGR of 6.90% to reach around USD 307.04 million by 2035. Rising prevalence of lung cancer, chronic obstructive pulmonary disease (COPD), asthma, and other airway conditions is driving demand for innovative stenting solutions.

Lung stents offer strategic value in improving patient outcomes, reducing surgical complications, and maintaining airway patency, making this market a critical segment for investors, healthcare decision-makers, and interventional pulmonology stakeholders.

What Are Lung Stents and Why Are They Important?

Lung stents are medical devices implanted in the trachea, bronchi, or larynx to keep the airway open, particularly in patients with obstructive respiratory conditions.

Clinical Significance

  • Maintain airway patency and improve breathing

  • Reduce the need for repeated surgical interventions

  • Facilitate targeted management of airway obstructions

  • Improve quality of life for patients with chronic respiratory conditions

Types of Lung Stents

  • Tracheobronchial Stents: Primarily for major airway obstructions

  • Laryngeal Stents: For upper airway and vocal cord interventions

What Are the Key Growth Drivers in the Lung Stent Market?

Rising Incidence of Respiratory Disorders

  • Increased prevalence of lung cancer, COPD, and asthma globally

  • Growing burden of chronic airway obstruction diseases

  • Expansion of screening and early diagnosis programs

Technological Advancements

  • Introduction of self-expandable and hybrid stents

  • Enhanced biocompatibility and flexibility of metal and silicon stents

  • Development of minimally invasive deployment techniques

Expanding Healthcare Infrastructure

  • Growth of hospitals and ambulatory surgery centers

  • Wider adoption of interventional pulmonology procedures

  • Increasing access to advanced stent technologies in developed and emerging markets

What Are the Emerging Trends in the Lung Stent Market?

Adoption of Self-Expandable Stents

  • Provides better conformability to airway geometry

  • Reduces stent migration risk

  • Facilitates simpler deployment in complex bronchial anatomies

Material Innovation

  • Hybrid stents combining metal strength and silicon flexibility

  • Focus on coatings to reduce granulation tissue formation

Customized and Patient-Specific Stents

  • 3D printing enables anatomy-specific stents

  • Reduces procedural complications and improves outcomes

Integration with Imaging Technologies

  • Bronchoscopic navigation systems ensure precise placement

  • AI-assisted imaging enables predictive airway management

How Is the Lung Stent Market Segmented?

By Type

  • Tracheobronchial Stents

  • Laryngeal Stents

By Material

  • Metal Stents: Durable and self-expanding

  • Silicon Stents: Flexible and removable

  • Hybrid Stents: Combines benefits of metal and silicon

By Product

  • Self-Expandable Stents: Adapts to airway geometry

  • Non-Expandable Stents: Provides rigid support

By End User

  • Hospitals: Largest segment due to complex case management

  • Ambulatory Surgery Centers: Growing adoption for minimally invasive procedures

  • Others: Specialty clinics and research hospitals

What Are the Regional Insights in the Lung Stent Market?

North America

  • Dominates the global market

  • High adoption due to advanced healthcare infrastructure and R&D

  • Significant prevalence of respiratory diseases

Europe

  • Key countries: Germany, France, UK

  • Strong network of interventional pulmonology centers

  • Supportive regulatory environment for innovative devices

Asia-Pacific

  • Fastest-growing region

  • Major contributors: China, Japan, India

  • Expansion driven by rising respiratory disease incidence and healthcare access

Latin America

  • Emerging adoption due to improving healthcare facilities

  • Focus on interventional pulmonology growth

Middle East & Africa

  • Developing markets with increasing awareness and investments in healthcare

  • Growth fueled by import of advanced stent technologies

Who Are the Major Players in the Lung Stent Market?

Key Companies

  • Boston Scientific Corporation

  • Taewoong Medical Co., Ltd.

  • Micro-Tech (Nanjing) Co., Ltd.

  • Bess Medizintechnik GmbH

  • E. Benson Hood Laboratories, Inc.

  • Merit Medical Systems, Inc.

  • Cook Group Incorporated

  • Boston Medical Products, Inc.

  • Novatech SA

  • Standard Sci. Tech Inc.

  • Stening SRL

  • ENDO-FLEX GmbH

Competitive Strategies

  • Product innovation and new stent designs

  • Strategic partnerships and collaborations

  • Market expansion into emerging economies

  • Focus on minimally invasive adoption and training programs

What Are the Challenges and Restraints in the Lung Stent Market?

High Cost of Advanced Stents

  • Limits adoption in emerging markets and smaller clinics

  • Premium stents such as self-expandable or hybrid models have higher price points

Regulatory Hurdles

  • Device approval requires rigorous clinical validation

  • Compliance with biocompatibility and safety standards

Risk of Complications

  • Migration, tissue overgrowth, and infections

  • Necessitates trained interventional pulmonologists

What Is the Future Outlook of the Lung Stent Market?

  • Expected to reach USD 307.04 million by 2035

  • Growth fueled by advanced stent materials, minimally invasive procedures, and rising respiratory disease prevalence

  • Personalized stents and AI-assisted placement will improve clinical outcomes

  • Expansion in Asia-Pacific, Latin America, and MEA presents new investment opportunities

View More Reports

Nanopore Sequencing Market

Osteoporosis Drug Pipeline Analysis Report

India Disposable Medical Gloves Market

CDMO Market Size

About Us:

Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.

Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.

Media Contact:

Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com